Australasian Antenatal Study To Evaluate the Role Of Intramuscular Dexamethasone versus Betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial

Phase 3

Completed

• Conditions: ong-term childhood neurosensory disability following antenatal corticosteroids given to women at risk of preterm birth at less than 34 weeks gestatation; Long-term childhood neurosensory disability following antenatal corticosteroids given to women at risk of preterm birth at less than 34 weeks gestatation; Reproductive Health and Childbirth - Antenatal care

• Registration Number: ACTRN12608000631303
• Lead Sponsor: Women’s and Children’s Hospital, SA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-12-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 1499

Inclusion Criteria

Women are eligible for the trial if they are at risk of preterm birth at less than 34 weeks gestation, have a singleton or twin pregnancy, have no contraindications to the use of antenatal corticosteroids and give informed consent.

Exclusion Criteria

Women are not eligible if they have chorioamnionitis requiring urgent delivery, a higher order multiple pregnancy, have already received antenatal corticosteroids, have known fetal lung maturation, or are in the second stage of labour.

Study & Design

• Study Type: Interventional
• Study Design: Not specified